Corporate Profile

Company NameElix, Inc.
CEOShinya Yuki
AddressDaini Togo Park Building 3F, 8-34 Yonbancho, Chiyoda-ku, Tokyo 102-0081 Japan
Main BanksMizuho Bank Shibuya Branch, Risona bank Ueno Branch
ClientsAsahi Kasei Corporation, Astellas Pharma Inc., Bridgestone Corporation, CAC Corporation, Chiba Institute of Technology, Honda R&D Co.,Ltd, KAKEN PHARMACEUTICAL CO., LTD., KONICA MINOLTA, INC., Graduate School of Medicine and Faculty of Medicine Kyoto University, NIPPON SHOKUBAI CO., LTD., Mitsubishi Chemical Holdings Corporation, Riken, Shionogi & Co., Ltd., Showa Denko K.K., Toppan Printing Co., Ltd.

Our History

November 4, 2016Established Elix, Inc. in Shibuya-ku, Tokyo, Japan
December 15, 2017Participated in the Life Intelligence Consortium (LINC)
February 1, 2018The headquarters of Elix, Inc. was relocated to 4-3-1, Toranomon, Minato-ku, Tokyo, Japan
October 4, 2019Selected for “Blockbuster TOKYO”, an acceleration program for pharmaceutical and medical startups
November 1, 2019The headquarters of Elix, Inc. was relocated to Daini Togo Park Building, 8-34 Yonbancho, Chiyoda-ku, Tokyo, Japan
July 7, 2020Entered into a joint research project on AI drug discovery with Astellas Pharma Inc.
October 20, 2021Released kMoL, a machine learning library for AI drug discovery library with federated learning capabilities, jointly developed with Kyoto University
December 20, 2021Entered into a joint collaboration with Shionogi & Co., Ltd. for verification of practical retrosynthetic analysis
May 1, 2022Launched our AI drug discovery platform, Elix Discovery™, and started providing AI consulting and implementation support to KAKEN PHARMACEUTICAL CO., LTD.
April 1, 2025Entered into a strategic collaboration agreement with PRISM BioLab Co., Ltd.

Access

Daini Togo Park Building 3F, 8-34 Yonbancho, Chiyoda-ku, Tokyo 102-0081 Japan

Access Access